Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study. [electronic resource]
Producer: 20191212Description: 817-828 p. digitalISSN:- 1433-2965
- Aged
- Alendronate -- therapeutic use
- Bone Density Conservation Agents -- therapeutic use
- Canada -- epidemiology
- Diphosphonates -- therapeutic use
- Etidronic Acid -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Osteoporosis -- drug therapy
- Osteoporotic Fractures -- mortality
- Prospective Studies
- Risedronic Acid -- therapeutic use
- Risk Factors
- Risk Reduction Behavior
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.